Nanoviricides (NNVC) Research & Development (2010 - 2026)
Nanoviricides (NNVC) posted Research & Development of $1.31 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 11.3% from $1.18 million a year earlier and up 1.9% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Research & Development (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides' Research & Development came in at $4.71 million, down 15.2% from FY2025.
- Annual Research & Development shows a five-year compound annual growth rate of -5.1% (FY2021 to FY2026).
- In prior fiscal years, Nanoviricides' Research & Development was $5.55 million in FY2025 (+2.1%), $5.44 million in FY2024 (-14.9%), $6.39 million in FY2023 (+10.5%) and $5.78 million in FY2022 (-5.4%).
- The fiscal Q4 2026 figure stands as the highest quarterly Research & Development since fiscal Q1 2025.
- On a year-over-year basis, Research & Development increased in four of the last eight quarters, with an average decline of 3.7%.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q4 2023, with growth of 148.6%; the weakest was fiscal Q4 2024, with a decline of 59.4%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $1.29 million (Q3 2026), $1.12 million (Q2 2026) and $993,066 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 993,066.00 |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 2.10 Mn |
API Access
Nanoviricides Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();